Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.

about

Implication of Rho-kinase and soluble guanylyl cyclase enzymes in prostate smooth muscle dysfunction in middle-aged rats.

P2860

Q55026414-81F8BF09-E954-49C8-9D61-C86AAD0CCEE0

P2860

Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.

Item

http://www.wikidata.org/entity/Q52923562

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Protective effect of hydroxyfa ...... pontaneously hypertensive rat.

@en

Protective effect of hydroxyfa ...... pontaneously hypertensive rat.

@nl

type

Item

label

Protective effect of hydroxyfa ...... pontaneously hypertensive rat.

@en

Protective effect of hydroxyfa ...... pontaneously hypertensive rat.

@nl

prefLabel

Protective effect of hydroxyfa ...... pontaneously hypertensive rat.

@en

Protective effect of hydroxyfa ...... pontaneously hypertensive rat.

@nl

P1476

Protective effect of hydroxyfa ...... pontaneously hypertensive rat.

@en

P2093

Darryl T Martin

http://www.w3.org/2001/XMLSchema#string

Felix Holmström

http://www.w3.org/2001/XMLSchema#string

Masashi Honda

http://www.w3.org/2001/XMLSchema#string

Motoaki Saito

http://www.w3.org/2001/XMLSchema#string

Shogo Shimizu

http://www.w3.org/2001/XMLSchema#string

Takahiro Shimizu

http://www.w3.org/2001/XMLSchema#string

Youichirou Higashi

http://www.w3.org/2001/XMLSchema#string

P2860

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.

Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.

Benign prostatic hyperplasia: age-related tissue-remodeling.

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia.

Rho-kinase: important new therapeutic target in cardiovascular diseases.

Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?

P304

1774-1782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23063

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26286428

http://www.w3.org/2001/XMLSchema#string

Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.

about

P2860

P2860

Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698